HVAC Systems and Airborne Infectious Disease Transmission Control

Airborne infectious disease transmission in occupied buildings is directly influenced by how HVAC systems filter, dilute, and circulate air. This page covers the mechanical and operational mechanisms through which heating, ventilation, and air conditioning infrastructure either reduces or amplifies pathogen exposure — including filtration efficiency, ventilation rate standards, humidity control, and supplemental air treatment technologies. The scope extends from regulatory frameworks established by ASHRAE and the CDC to the classification of aerosol transmission pathways and the practical tradeoffs that arise when upgrading systems for infection control. Understanding these relationships is essential for facility operators, code authorities, and engineers responsible for occupied building environments.

• Definition and scope
• Core mechanics or structure
• Causal relationships or drivers
• Classification boundaries
• Tradeoffs and tensions
• Common misconceptions
• Checklist or steps (non-advisory)
• Reference table or matrix
• References

Definition and scope

Airborne infectious disease transmission control, in the context of HVAC systems, refers to the deliberate design and operation of building mechanical systems to reduce the concentration and spread of viable pathogen-containing aerosols in indoor air. This is distinct from general indoor air quality management — it specifically targets biological agents capable of causing infection when inhaled, ingested via mucous membrane contact, or deposited on surfaces through aerosol settling.

The relevant pathogens include respiratory viruses (influenza, SARS-CoV-2, rhinovirus), bacterial agents (Mycobacterium tuberculosis, Legionella pneumophila), and fungal spores (Aspergillus species in immunocompromised care environments). Aerosol particle sizes range from sub-micron droplet nuclei (less than 5 µm) — which remain suspended for extended periods — to larger respiratory droplets (greater than 100 µm) that settle quickly under gravity. The HVAC transmission control problem is primarily concerned with the sub-5-µm fraction, since larger droplets fall before mechanical air distribution can carry them across a space.

Scope boundaries matter for regulatory and design purposes. HVAC-based infection control is addressed under ASHRAE Standard 62.1 (ventilation for acceptable indoor air quality), ASHRAE Standard 170 (ventilation of health care facilities), ASHRAE Epidemic Task Force guidance published in 2020 and 2021, and CDC guidelines for environmental infection control in health-care facilities (CDC/HICPAC, 2003). Occupational settings are additionally regulated under OSHA 29 CFR Part 1910 for general industry, with specific TB control provisions. Building codes in jurisdictions adopting ASHRAE 62.1 or 170 make ventilation rates legally enforceable minimum thresholds. The current edition of ASHRAE 62.1 is the 2022 edition, which took effect January 1, 2022.

Core mechanics or structure

HVAC systems influence airborne disease transmission through four primary mechanisms: dilution ventilation, filtration, pressure relationship control, and supplemental germicidal treatment.

Dilution ventilation introduces outdoor or recirculated clean air to reduce the concentration of airborne contaminants in a space. The Wells-Riley equation — a foundational epidemiological model — describes infection risk as a function of quanta generation rate, pulmonary ventilation rate of susceptibles, room volume, and air exchange rate. Increasing air changes per hour (ACH) directly reduces the steady-state concentration of infectious quanta. ASHRAE Standard 62.1-2022 sets minimum outdoor air delivery rates by occupancy category, expressed in cubic feet per minute per person (cfm/person) and cfm per square foot. Healthcare occupancies under ASHRAE 170 require higher minimums: operating rooms, for example, require a minimum of 20 ACH total air supply (ASHRAE Standard 170-2021).

Filtration captures particles as air passes through filter media. The MERV (Minimum Efficiency Reporting Value) scale, defined in ASHRAE Standard 52.2, rates filters on their ability to capture particles in three size ranges. MERV 13 filters capture at least 50% of particles in the 0.3–1.0 µm range and at least 85% of particles in the 1.0–3.0 µm range — the size range most relevant to respiratory aerosol nuclei. HEPA (High Efficiency Particulate Air) filters, addressed in HEPA filtration in HVAC systems, capture at least 99.97% of particles at 0.3 µm by DOE definition. Filter selection intersects directly with MERV ratings explained and the practical constraints of existing duct systems.

Pressure relationship control uses engineered pressure differentials between spaces to direct airflow from lower-risk to higher-risk zones, preventing contaminated air migration. Airborne infection isolation (AII) rooms in hospitals maintain negative pressure relative to adjacent corridors — a minimum of 0.01 inches of water gauge negative pressure per CDC/HICPAC guidance. Protective environment (PE) rooms for immunocompromised patients maintain positive pressure.

Supplemental germicidal treatment includes upper-room ultraviolet germicidal irradiation (UVGI), in-duct UV-C systems, and portable air cleaners. Upper-room UVGI fixtures irradiate the air column above 7 feet, inactivating airborne organisms through UV-C exposure at 254 nm. The CDC and NIOSH have published guidance on upper-room UVGI design parameters. UV air purification in HVAC covers system-type distinctions in greater detail.

Causal relationships or drivers

The causal chain linking HVAC operation to infection risk is well-documented through epidemiological investigations. Inadequate ventilation rates are consistently identified as a contributing factor in documented nosocomial outbreaks, including multi-patient TB transmission events in healthcare settings investigated by CDC. Legionella pneumophila outbreaks — which cause Legionnaires' disease — are causally linked to cooling tower drift and potable water distribution systems, not airborne HVAC recirculation per se, but they illustrate the principle that mechanical systems create defined exposure pathways.

Low relative humidity (below 40% RH) extends the viability and suspension time of many respiratory viruses. High humidity (above 60% RH) promotes mold growth and dust mite proliferation. HVAC humidity control and air quality covers the 40–60% RH operating band that ASHRAE guidance identifies as minimizing both pathogen viability and secondary biological growth. Maintaining this band requires functional humidification and dehumidification capacity, both of which impose energy loads.

Recirculation systems without adequate filtration can redistribute pathogens across zones served by a common air handling unit. This was documented in a 1979 Legionella outbreak investigation at a hotel and has been studied in the context of influenza transmission in aircraft cabin environments. Single-pass (100% outdoor air) systems eliminate recirculation risk at the cost of significant energy expenditure.

Classification boundaries

Airborne transmission control strategies can be classified along two axes: intervention type (source control vs. pathway interruption vs. receptor protection) and system integration level (central HVAC modification vs. local/portable supplementation vs. room-level engineering controls).

Source control addresses the infected individual directly — through masking, isolation, or negative-pressure containment. Pathway interruption is where HVAC systems operate: dilution, filtration, UV inactivation, and pressure differentials. Receptor protection involves personal protective equipment and ventilation design that minimizes exposure at breathing zones.

Within HVAC-based pathway interventions, a further classification distinguishes primary system modifications (upgrading central AHU filtration to MERV 13+, increasing outdoor air fractions, installing UV-C in air handling units) from supplemental room-level controls (portable HEPA air cleaners, upper-room UVGI fixtures, localized exhaust). Healthcare facilities governed by ASHRAE 170 and FGI Guidelines have mandatory requirements in both categories. Commercial and institutional buildings under ASHRAE 62.1-2022 have mandatory ventilation minima but not specific infection-control filtration requirements, leaving upgrade decisions to building owners and facility managers. HVAC air quality in schools and healthcare covers occupancy-specific regulatory layers.

Tradeoffs and tensions

The primary tension in HVAC-based infection control is between pathogen reduction effectiveness and energy consumption. Increasing outdoor air fractions, upgrading to MERV 13 or HEPA filtration, and running systems at higher ACH rates all impose measurable energy penalties. MERV 13 filters create higher static pressure drop than MERV 8 filters, requiring fan systems with greater capacity or accepting reduced airflow — both of which have design and cost implications. Energy recovery ventilators (ERVs), discussed at energy recovery ventilators and air quality, partially offset the thermal penalty of increased outdoor air intake.

A second tension exists between infection control and thermal comfort. Increasing ventilation rates in cold climates requires conditioning large volumes of cold dry outdoor air, which can drive indoor RH below the 40% threshold that supports pathogen viability reduction — creating a self-defeating dynamic in winter operation.

A third tension involves cross-contamination via recirculation. Systems designed for energy efficiency — variable air volume (VAV) systems with extensive recirculation — are architecturally opposed to the single-pass, 100% outdoor air configurations that provide the most robust infection control. Retrofitting existing commercial VAV systems for infection control typically requires a staged approach: filtration upgrade first, outdoor air fraction increase second, supplemental treatment third.

The regulatory tension is that ASHRAE 62.1 minimum ventilation rates were not designed as infection control standards. ASHRAE's own Epidemic Task Force publications from 2020 acknowledged that compliance with 62.1-2022 minimums does not guarantee adequate dilution for high-quanta-generating respiratory pathogens in high-density occupancies.

Common misconceptions

Misconception: MERV 13 filtration eliminates airborne transmission risk.
MERV 13 reduces the concentration of aerosol particles in the 1–3 µm range by at least 85% per pass, but single-pass efficiency does not equate to room-level exposure elimination. Pathogen-laden air that bypasses filters through leakage paths around the filter bank — a common installation deficiency — reduces realized efficiency substantially. Filter frame fit and bypass leakage are as operationally significant as rated filter efficiency.

Misconception: UV-C systems in ducts provide real-time air disinfection.
In-duct UV-C systems are primarily effective for continuous surface irradiation of cooling coils and drain pans (controlling mold and biofilm), not for real-time aerosol disinfection. At typical duct air velocities (400–600 feet per minute), the UV-C exposure dwell time is insufficient to achieve meaningful germicidal dose for most respiratory pathogens. Upper-room UVGI at lower air velocities is the evidence-supported configuration for real-time aerosol inactivation.

Misconception: Portable air cleaners are equivalent to central HVAC upgrades.
Portable HEPA air cleaners can provide meaningful equivalent ACH in specific rooms — the CDC and ASHRAE have published calculations for clean air delivery rate (CADR) relative to room volume — but they do not address building-wide recirculation, pressure relationships, or outdoor air delivery. They function as supplemental controls, not substitutes for central system performance.

Misconception: Higher ACH always reduces infection risk proportionally.
The Wells-Riley model predicts diminishing returns at high ACH values. Moving from 2 ACH to 6 ACH produces a larger proportional risk reduction than moving from 6 ACH to 10 ACH. The relationship is nonlinear; the marginal benefit of ACH increases above approximately 12 ACH is small relative to energy cost.

Checklist or steps (non-advisory)

The following sequence identifies the technical evaluation steps typically applied when assessing an HVAC system for airborne infectious disease transmission control capacity. This is a documentation framework, not professional engineering guidance.

1. Establish baseline ventilation rates — Measure or calculate actual outdoor air delivery (cfm/person and ACH) for each occupied zone. Compare against applicable standards: ASHRAE 62.1-2022 for commercial, ASHRAE 170 for healthcare.
2. Audit filter installation and rating — Identify installed MERV rating, verify filter bank seating and bypass leakage, confirm filter change schedule compliance. Note whether installed fan capacity supports upgrade to MERV 13 without airflow reduction.
3. Document recirculation pathways — Map which zones share air handling units and return air plenums. Identify whether zone-to-zone cross-contamination pathways exist through recirculated air.
4. Assess pressure relationships — Verify that any isolation rooms, procedure rooms, or high-risk zones maintain documented design pressure differentials. Confirm presence of pressure gauges or monitoring alarms per applicable code.
5. Evaluate humidity control capacity — Confirm humidification and dehumidification equipment capacity to maintain 40–60% RH under design heating and cooling conditions.
6. Inventory supplemental treatment systems — Document presence, placement, and maintenance status of UV-C systems, ionization systems, or portable air cleaners. Verify that UV air purification and electronic air cleaner installations follow manufacturer and ASHRAE guidance.
7. Review maintenance records — Confirm coil cleaning, drain pan treatment, and filter change records. Biological growth on cooling coils and drain pans is a pathogen amplification source independent of airborne transmission.
8. Cross-reference applicable regulatory requirements — Identify which standards govern the facility (ASHRAE 62.1-2022, ASHRAE 170, FGI Guidelines, state health department regulations, OSHA TB control provisions) and document gaps between current performance and minimum thresholds.

Reference table or matrix

HVAC Infection Control Strategies: Parameters and Regulatory Context

References

• ASHRAE Standard 62.1-2022 — Ventilation and Acceptable Indoor Air Quality
• ASHRAE Standard 170-2021 — Ventilation of Health Care Facilities
• ASHRAE Standard 52.2 — Method of Testing General Ventilation Air-Cleaning Devices
• ASHRAE Epidemic Task Force — Building Readiness and Core Recommendations (2020–2021)
• CDC/HICPAC — Guidelines for Environmental Infection Control in Health-Care Facilities (2003)